Search for: "Watson v. Attorney General, Office of et al"
Results 1 - 19
of 19
Sorted by Relevance
|
Sort by Date
18 Jan 2015, 4:30 am
Canada (Attorney General), 2014 FC 1243 http://t.co/SxCrxjq2we -> Letter of Request in patent case enforced in Arctic Cat Inc. et al. v. [read post]
12 Jan 2007, 10:34 am
That case is Watson, et al., v. [read post]
2 Jan 2013, 3:17 pm
Kennedy et al FLSD Other Civil Rights Americans with Disabilities Act Boehm et al v. [read post]
27 Apr 2010, 10:58 pm
Orthofix International N.V. et al. [read post]
30 Jun 2014, 10:28 am
In these "Effient" patent-defense lawsuits, Lilly et al. assert allegations of infringement of Effient. [read post]
12 Jan 2007, 10:34 am
That case is Watson, et al., v. [read post]
20 Nov 2009, 9:25 am
(Justice Willett not sitting) Dissent from denial of review: Shane Watson v. [read post]
17 Jul 2014, 10:58 am
Patent Office. [read post]
27 Aug 2023, 3:56 pm
GENERAL QUESTIONS ABOUT REMOVAL What is the basis for removing a state prosecution to federal court? [read post]
15 Mar 2024, 1:45 pm
McCraw, Director, Texas Department Of Public Safety, et al. [read post]
29 Aug 2022, 9:05 pm
At the FTC, for example, Second Requests have been staffed with only one lawyer and one economist (while a typical Second Request would usually have much larger teams of lawyers and economists), and the FTC has begun asking attorneys from its Consumer Protection and Policy Planning offices to review mergers (frequently a new role for these lawyers).11 The agencies have also been pressing parties for more stringent requirements during the merger review. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
17 Oct 2007, 5:39 pm
Brown et al., No. 06-30134, 2007 WL 2828869 (D. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
9 Apr 2022, 3:01 am
Karen Bass et al. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
20 Nov 2022, 9:55 am
In the Fourth Circuit, Maryland Attorney General Frosh is defending a Maryland ban on many common rifles. [read post]
28 Dec 2015, 2:51 am
Copyright Office released a comprehensive study, “Copyright and the Music Marketplace” detailing the ageing music licensing framework as well as the ever-evolving needs of those who create and invest in music in the twenty-first century. [read post]
29 Jun 2010, 1:34 am
SOMA ENVIRONMENTAL ENGINEERING, INC., et al., Defendants and Respondents. [read post]
